Type |
Details |
Score |
Publication |
First Author: |
Strine MS |
Year: |
2023 |
Journal: |
PLoS Biol |
Title: |
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner. |
Volume: |
21 |
Issue: |
6 |
Pages: |
e3002097 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang J |
Year: |
2020 |
Journal: |
Nature |
Title: |
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Guimarães GG |
Year: |
2012 |
Journal: |
Peptides |
Title: |
Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice. |
Volume: |
38 |
Issue: |
1 |
Pages: |
54-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brar GS |
Year: |
2017 |
Journal: |
Diabetes |
Title: |
Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). |
Volume: |
66 |
Issue: |
8 |
Pages: |
2201-2212 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang W |
Year: |
2019 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs. |
Volume: |
116 |
Issue: |
26 |
Pages: |
13006-13015 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ali Q |
Year: |
2016 |
Journal: |
J Renin Angiotensin Aldosterone Syst |
Title: |
Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury. |
Volume: |
17 |
Issue: |
3 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Liao MC |
Year: |
2021 |
Journal: |
Diabetologia |
Title: |
AT2R deficiency in mice accelerates podocyte dysfunction in diabetic progeny in a sex-dependent manner. |
Volume: |
64 |
Issue: |
9 |
Pages: |
2108-2121 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iwanami J |
Year: |
2014 |
Journal: |
Hypertens Res |
Title: |
Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan. |
Volume: |
37 |
Issue: |
7 |
Pages: |
616-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tanno T |
Year: |
2016 |
Journal: |
J Cardiovasc Pharmacol |
Title: |
Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression. |
Volume: |
67 |
Issue: |
6 |
Pages: |
503-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ichikawa H |
Year: |
2018 |
Journal: |
Int Heart J |
Title: |
Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin. |
Volume: |
59 |
Issue: |
6 |
Pages: |
1445-1453 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sato T |
Year: |
2019 |
Journal: |
Int J Mol Sci |
Title: |
Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling. |
Volume: |
20 |
Issue: |
2 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Shi Y |
Year: |
2013 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice. |
Volume: |
304 |
Issue: |
11 |
Pages: |
F1335-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lo CS |
Year: |
2012 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. |
Volume: |
302 |
Issue: |
7 |
Pages: |
F840-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Feng Y |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. |
Volume: |
7 |
Issue: |
11 |
Pages: |
e48910 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xia H |
Year: |
2013 |
Journal: |
Circ Res |
Title: |
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. |
Volume: |
113 |
Issue: |
9 |
Pages: |
1087-1096 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weiss CM |
Year: |
2023 |
Journal: |
PLoS One |
Title: |
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2. |
Volume: |
18 |
Issue: |
8 |
Pages: |
e0289139 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suryawanshi RK |
Year: |
2022 |
Journal: |
Nature |
Title: |
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. |
Volume: |
607 |
Issue: |
7918 |
Pages: |
351-355 |
|
•
•
•
•
•
|
Publication |
First Author: |
Halfmann PJ |
Year: |
2022 |
Journal: |
Nature |
Title: |
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. |
Volume: |
603 |
Issue: |
7902 |
Pages: |
687-692 |
|
•
•
•
•
•
|
Publication |
First Author: |
Solopov PA |
Year: |
2022 |
Journal: |
Am J Pathol |
Title: |
Alcohol Increases Lung Angiotensin-Converting Enzyme 2 Expression and Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Subunit 1-Induced Acute Lung Injury in K18-hACE2 Transgenic Mice. |
Volume: |
192 |
Issue: |
7 |
Pages: |
990-1000 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu B |
Year: |
2023 |
Journal: |
EBioMedicine |
Title: |
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract. |
Volume: |
99 |
|
Pages: |
104916 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moreau GB |
Year: |
2020 |
Journal: |
Am J Trop Med Hyg |
Title: |
Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hong J |
Year: |
2022 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants. |
Volume: |
119 |
Issue: |
18 |
Pages: |
e2201433119 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wagner TR |
Year: |
2022 |
Journal: |
EMBO Rep |
Title: |
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern. |
Volume: |
23 |
Issue: |
2 |
Pages: |
e53865 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rawle DJ |
Year: |
2021 |
Journal: |
PLoS Pathog |
Title: |
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions. |
Volume: |
17 |
Issue: |
7 |
Pages: |
e1009723 |
|
•
•
•
•
•
|
Publication |
First Author: |
Case JB |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains. |
Volume: |
13 |
Issue: |
1 |
Pages: |
3824 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chaouat AE |
Year: |
2021 |
Journal: |
PLoS Pathog |
Title: |
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection. |
Volume: |
17 |
Issue: |
12 |
Pages: |
e1010175 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Oosten L |
Year: |
2021 |
Journal: |
mBio |
Title: |
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants. |
Volume: |
12 |
Issue: |
5 |
Pages: |
e0181321 |
|
•
•
•
•
•
|
Publication |
First Author: |
El-Shennawy L |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. |
Volume: |
13 |
Issue: |
1 |
Pages: |
405 |
|
•
•
•
•
•
|
Publication |
First Author: |
Casasnovas JM |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron. |
Volume: |
13 |
|
Pages: |
863831 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lu T |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19. |
Volume: |
13 |
Issue: |
1 |
Pages: |
2576 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barbier M |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2. |
Volume: |
13 |
|
Pages: |
948431 |
|
•
•
•
•
•
|
Publication |
First Author: |
Golden JW |
Year: |
2020 |
Journal: |
JCI Insight |
Title: |
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Shapira T |
Year: |
2022 |
Journal: |
Nature |
Title: |
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. |
Volume: |
605 |
Issue: |
7909 |
Pages: |
340-348 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lennol MP |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy. |
Volume: |
13 |
|
Pages: |
1001951 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lende SSF |
Year: |
2023 |
Journal: |
PLoS One |
Title: |
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster. |
Volume: |
18 |
Issue: |
9 |
Pages: |
e0291131 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chan CEZ |
Year: |
2021 |
Journal: |
PLoS One |
Title: |
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody. |
Volume: |
16 |
Issue: |
6 |
Pages: |
e0253487 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu J |
Year: |
2021 |
Journal: |
Nature |
Title: |
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. |
Volume: |
595 |
Issue: |
7866 |
Pages: |
278-282 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kamle S |
Year: |
2021 |
Journal: |
JCI Insight |
Title: |
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. |
Volume: |
6 |
Issue: |
21 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Guo X |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2. |
Volume: |
13 |
Issue: |
1 |
Pages: |
7907 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li W |
Year: |
2020 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. |
Volume: |
117 |
Issue: |
47 |
Pages: |
29832-29838 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bindom SM |
Year: |
2010 |
Journal: |
Diabetes |
Title: |
Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. |
Volume: |
59 |
Issue: |
10 |
Pages: |
2540-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chodavarapu H |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. |
Volume: |
8 |
Issue: |
4 |
Pages: |
e62833 |
|
•
•
•
•
•
|
Publication |
First Author: |
Somineni HK |
Year: |
2014 |
Journal: |
J Endocrinol |
Title: |
Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice. |
Volume: |
221 |
Issue: |
2 |
Pages: |
235-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang K |
Year: |
2023 |
Journal: |
Signal Transduct Target Ther |
Title: |
SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cells. |
Volume: |
8 |
Issue: |
1 |
Pages: |
276 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bae EH |
Year: |
2015 |
Journal: |
Am J Pathol |
Title: |
Characterization of the intrarenal renin-angiotensin system in experimental alport syndrome. |
Volume: |
185 |
Issue: |
5 |
Pages: |
1423-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Choi HS |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Angiotensin-[1-7] attenuates kidney injury in experimental Alport syndrome. |
Volume: |
10 |
Issue: |
1 |
Pages: |
4225 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suh SH |
Year: |
2019 |
Journal: |
Int J Mol Sci |
Title: |
Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ. |
Volume: |
20 |
Issue: |
15 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Faber F |
Year: |
2006 |
Journal: |
Regul Pept |
Title: |
Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice. |
Volume: |
136 |
Issue: |
1-3 |
Pages: |
130-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dominguez JM 2nd |
Year: |
2016 |
Journal: |
Am J Pathol |
Title: |
Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice. |
Volume: |
186 |
Issue: |
6 |
Pages: |
1688-700 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rockx B |
Year: |
2009 |
Journal: |
J Virol |
Title: |
Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. |
Volume: |
83 |
Issue: |
14 |
Pages: |
7062-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xie W |
Year: |
2020 |
Journal: |
World Neurosurg |
Title: |
OIP5-AS1 attenuates microangiopathy in diabetic mouse by regulating miR-200b/ACE2. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ribeiro AA |
Year: |
2015 |
Journal: |
J Renin Angiotensin Aldosterone Syst |
Title: |
Characterization of the renal renin-angiotensin system in transgenic mice that express rat tonin. |
Volume: |
16 |
Issue: |
4 |
Pages: |
947-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang R |
Year: |
2020 |
Journal: |
EBioMedicine |
Title: |
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections. |
Volume: |
58 |
|
Pages: |
102890 |
|
•
•
•
•
•
|
Publication |
First Author: |
Obukhov AG |
Year: |
2020 |
Journal: |
Diabetes |
Title: |
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes. |
Volume: |
69 |
Issue: |
9 |
Pages: |
1875-1886 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brooke GN |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Structural and functional modelling of SARS-CoV-2 entry in animal models. |
Volume: |
10 |
Issue: |
1 |
Pages: |
15917 |
|
•
•
•
•
•
|
Publication |
First Author: |
Myti D |
Year: |
2020 |
Journal: |
Am J Physiol Lung Cell Mol Physiol |
Title: |
Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium. |
Volume: |
319 |
Issue: |
4 |
Pages: |
L670-L674 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li S |
Year: |
2021 |
Journal: |
JCI Insight |
Title: |
Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity. |
Volume: |
6 |
Issue: |
2 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Chadchan SB |
Year: |
2021 |
Journal: |
Biol Reprod |
Title: |
The SARS-CoV-2 receptor, angiotensin-converting enzyme 2, is required for human endometrial stromal cell decidualization†. |
Volume: |
104 |
Issue: |
2 |
Pages: |
336-343 |
|
•
•
•
•
•
|
Publication |
First Author: |
Case JB |
Year: |
2022 |
Journal: |
bioRxiv |
Title: |
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-COV-2 Omicron lineage strains. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bolkhovitina EL |
Year: |
2022 |
Journal: |
bioRxiv |
Title: |
The SARS-CoV-2 receptor-binding domain facilitates neutrophil transepithelial migration and nanoparticle uptake in the mice airways. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Abdelnabi R |
Year: |
2022 |
Journal: |
bioRxiv |
Title: |
A SCID mouse model to evaluate the efficacy of antivirals against SARS-CoV-2 infection. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Yuan L |
Year: |
2020 |
Journal: |
Emerg Microbes Infect |
Title: |
Animal models for emerging coronavirus: progress and new insights. |
Volume: |
9 |
Issue: |
1 |
Pages: |
949-961 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Publication |
First Author: |
Scaglione A |
Year: |
2021 |
Journal: |
Front Immunol |
Title: |
Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity. |
Volume: |
12 |
|
Pages: |
719077 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fessler MB |
Year: |
2023 |
Journal: |
Am J Respir Cell Mol Biol |
Title: |
Endogenous and Therapeutic 25-Hydroxycholesterols May Worsen Early SARS-CoV-2 Pathogenesis in Mice. |
Volume: |
69 |
Issue: |
6 |
Pages: |
638-648 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiao L |
Year: |
2011 |
Journal: |
Hypertension |
Title: |
Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure. |
Volume: |
58 |
Issue: |
6 |
Pages: |
1057-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khaddaj-Mallat R |
Year: |
2021 |
Journal: |
Neurobiol Dis |
Title: |
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein. |
Volume: |
161 |
|
Pages: |
105561 |
|
•
•
•
•
•
|
Publication |
First Author: |
Colunga Biancatelli RML |
Year: |
2021 |
Journal: |
Am J Physiol Lung Cell Mol Physiol |
Title: |
The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. |
Volume: |
321 |
Issue: |
2 |
Pages: |
L477-L484 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wei WC |
Year: |
2023 |
Journal: |
Front Pharmacol |
Title: |
NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model. |
Volume: |
14 |
|
Pages: |
1125414 |
|
•
•
•
•
•
|
Publication |
First Author: |
Izadpanah A |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
SARS-CoV-2 infection dysregulates NAD metabolism. |
Volume: |
14 |
|
Pages: |
1158455 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giannakopoulos S |
Year: |
2023 |
Journal: |
PLoS Pathog |
Title: |
In vitro evidence against productive SARS-CoV-2 infection of human testicular cells: Bystander effects of infection mediate testicular injury. |
Volume: |
19 |
Issue: |
5 |
Pages: |
e1011409 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim SH |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits. |
Volume: |
13 |
|
Pages: |
1055811 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rajapaksha IG |
Year: |
2019 |
Journal: |
Hepatol Commun |
Title: |
Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice. |
Volume: |
3 |
Issue: |
12 |
Pages: |
1656-1673 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zeng J |
Year: |
2022 |
Journal: |
EBioMedicine |
Title: |
Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice. |
Volume: |
75 |
|
Pages: |
103803 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shmakova AA |
Year: |
2023 |
Journal: |
Int J Mol Sci |
Title: |
Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19. |
Volume: |
24 |
Issue: |
2 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mercure C |
Year: |
2008 |
Journal: |
Circ Res |
Title: |
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. |
Volume: |
103 |
Issue: |
11 |
Pages: |
1319-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu R |
Year: |
2020 |
Journal: |
Eur J Med Res |
Title: |
miR-34a targets PAI-1 to regulate urinary microalbumin and renal function in hypertensive mice. |
Volume: |
25 |
Issue: |
1 |
Pages: |
3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee SH |
Year: |
2020 |
Journal: |
Lab Anim Res |
Title: |
Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2. |
Volume: |
36 |
|
Pages: |
23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brooks SD |
Year: |
2021 |
Journal: |
bioRxiv |
Title: |
Oral lisinopril raises tissue levels of ACE2, the SARS-CoV-2 receptor, in healthy male and female mice. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Agarwal S |
Year: |
2022 |
Journal: |
bioRxiv |
Title: |
Dietary alphaKG inhibits SARS CoV-2 infection and rescues inflamed lungs to restore normal O2 saturation in animals. |
|
|
|
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
477
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
477
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
477
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
482
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Stegbauer J |
Year: |
2019 |
Journal: |
J Vasc Surg |
Title: |
Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice. |
Volume: |
70 |
Issue: |
5 |
Pages: |
1658-1668.e1 |
|
•
•
•
•
•
|
Publication |
First Author: |
Awosanya OD |
Year: |
2022 |
Journal: |
Bone |
Title: |
Osteoclast-mediated bone loss observed in a COVID-19 mouse model. |
Volume: |
154 |
|
Pages: |
116227 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen JS |
Year: |
2021 |
Journal: |
J Virol |
Title: |
Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Chen JS |
Year: |
2020 |
Journal: |
bioRxiv |
Title: |
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Pan R |
Year: |
2022 |
Journal: |
mBio |
Title: |
N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition. |
Volume: |
13 |
Issue: |
1 |
Pages: |
e0366221 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alawi LF |
Year: |
2020 |
Journal: |
Front Pharmacol |
Title: |
Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension. |
Volume: |
11 |
|
Pages: |
602985 |
|
•
•
•
•
•
|
Publication |
First Author: |
Abdelnabi R |
Year: |
2022 |
Journal: |
J Virol |
Title: |
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection. |
Volume: |
96 |
Issue: |
16 |
Pages: |
e0075822 |
|
•
•
•
•
•
|
Publication |
First Author: |
Low BE |
Year: |
2022 |
Journal: |
Sci Rep |
Title: |
Efficient targeted transgenesis of large donor DNA into multiple mouse genetic backgrounds using bacteriophage Bxb1 integrase. |
Volume: |
12 |
Issue: |
1 |
Pages: |
5424 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lau SK |
Year: |
2010 |
Journal: |
J Virol |
Title: |
Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup. |
Volume: |
84 |
Issue: |
21 |
Pages: |
11385-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo Y |
Year: |
2018 |
Journal: |
Virol Sin |
Title: |
Longitudinal Surveillance of Betacoronaviruses in Fruit Bats in Yunnan Province, China During 2009-2016. |
Volume: |
33 |
Issue: |
1 |
Pages: |
87-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tai W |
Year: |
2020 |
Journal: |
Cell Mol Immunol |
Title: |
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. |
Volume: |
17 |
Issue: |
6 |
Pages: |
613-620 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li F |
Year: |
2016 |
Journal: |
Annu Rev Virol |
Title: |
Structure, Function, and Evolution of Coronavirus Spike Proteins. |
Volume: |
3 |
Issue: |
1 |
Pages: |
237-261 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shang J |
Year: |
2020 |
Journal: |
PLoS Pathog |
Title: |
Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. |
Volume: |
16 |
Issue: |
3 |
Pages: |
e1008392 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lubin JH |
Year: |
2022 |
Journal: |
Proteins |
Title: |
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic. |
Volume: |
90 |
Issue: |
5 |
Pages: |
1054-1080 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rawlings ND |
Year: |
1995 |
Journal: |
Methods Enzymol |
Title: |
Evolutionary families of metallopeptidases. |
Volume: |
248 |
|
Pages: |
183-228 |
|
•
•
•
•
•
|